Pfizer () shares are up 13% year to date, and the company reports its second-quarter earnings on Aug. 2. Expect a strong second quarter, as Pfizer is executing exceptionally well.
Pfizer reported its first quarter on May 3 and beat the consensus estimate by 12 cents per share. Earnings were 67 cents a share and revenue rose 19.3% to $13.01 billion vs. the $12 billion Street estimate.
The better-than-expected quarter came from sales...
More